English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  Expansion of the genotypic and phenotypic spectrum in patients with KRAS germline mutations.

Zenker, M., Lehmann, K., Schulz, A. L., Barth, H., Hansmann, D., Koenig, R., et al. (2007). Expansion of the genotypic and phenotypic spectrum in patients with KRAS germline mutations. Journal of Medical Genetics, 44(2), 131-135. doi:10.1136/jmg.2006.046300.

Item is

Basic

show hide
Genre: Journal Article
Alternative Title : J. Med. Genet.

Files

show Files
hide Files
:
131.pdf (Any fulltext), 728KB
 
File Permalink:
-
Name:
131.pdf
Description:
-
OA-Status:
Visibility:
Restricted (Max Planck Institute for Molecular Genetics, MBMG; )
MIME-Type / Checksum:
application/pdf
Technical Metadata:
Copyright Date:
-
Copyright Info:
eDoc_access: INSTITUT
License:
-

Locators

show

Creators

show
hide
 Creators:
Zenker, Martin, Author
Lehmann, Katarina, Author
Schulz, Anna Leana, Author
Barth, Helmut, Author
Hansmann, Dagmar, Author
Koenig, Rainer, Author
Korinthenberg, Rudolf, Author
Kreiss-Nachtsheim, Martina, Author
Meinecke, Peter, Author
Morlot, Susanne, Author
Mundlos, Stefan1, Author           
Quante, Anne S., Author
Raskin, Salmo, Author
Schnabel, Dirk, Author
Wehner, Lars-Erik, Author
Kratz, Christian P., Author
Horn, Denise, Author
Kutsche, Kerstin, Author
Affiliations:
1Research Group Development & Disease (Head: Stefan Mundlos), Max Planck Institute for Molecular Genetics, Max Planck Society, ou_1433557              

Content

show
hide
Free keywords: -
 Abstract: Background: Noonan syndrome, cardio-facio-cutaneous syndrome (CFC) and Costello syndrome constitute a group of developmental disorders with an overlapping pattern of congenital anomalies. Each of these conditions can be caused by germline mutations in key components of the highly conserved Ras-MAPK pathway, possibly reflecting a similar pathogenesis underlying the three disorders. Germline mutations in KRAS have recently been identified in a small number of patients with Noonan syndrome and CFC. Methods and results: 260 patients were screened for KRAS mutations by direct sequencing. Overall, we detected KRAS mutations in 12 patients, including three known and eight novel sequence alterations. All mutations are predicted to cause single amino acid substitutions. Remarkably, our cohort of individuals with KRAS mutations showed a high clinical variability, ranging from Noonan syndrome to CFC, and also included two patients who met the clinical criteria of Costello syndrome. Conclusion: Our findings reinforce the picture of a clustered distribution of disease associated KRAS germline alterations. We further defined the phenotypic spectrum associated with KRAS missense mutations and provided the first evidence of clinical differences in patients with KRAS mutations compared with Noonan syndrome affected individuals with heterozygous PTPN11 mutations and CFC patients carrying a BRAF, MEK1 or MEK1 alteration, respectively. We speculate that the observed phenotypic variability may be related, at least in part, to specific genotypes and possibly reflects the central role of K-Ras in a number of different signalling pathways.

Details

show
hide
Language(s): eng - English
 Dates: 2007-02-01
 Publication Status: Issued
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: -
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Journal of Medical Genetics
  Alternative Title : J. Med. Genet.
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: 44 (2) Sequence Number: - Start / End Page: 131 - 135 Identifier: ISSN: 0022-2593